16 Results for "

LGR5

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "LGR5" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-117163
CAS No.: 2204290-85-5
Purity:  98.93%
Target:  

Wnt β-catenin PI3K Akt c-Myc CDK

Research Areas:  

Cancer

FzM1.8 is a Wnt/β-catenin signaling pathway agonist and an allosteric agonist of Frizzled 4 (FZD4), with a pEC50 of 6.4 for FZD4 . FzM1.8 stabilizes a conformation with increased affinity for heterotrimeric G proteins, promoting Gβγ release and subsequent PI3K activation. FzM1.8 activates the AKT pathway downstream of FZD4. FzM1.8 does not affect FZD4 maturation or plasma membrane localization and does not induce FZD4 endocytosis. FzM1.8 upregulates the WNT-responsive genes C-myc and Cyclin D1, while leaving lgr5 expression unchanged. FzM1.8 can be used for colon cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P79308
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LGR5; G-Protein Coupled Receptor HG38; Prev. GPR49; G-Protein Coupled Receptor 49; Prev. GPR67; G-Protein Coupled Receptor 67; HG38; Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5, Isoform CRA_b; FEX; Orphan G Protein-Coupled Receptor HG38; Leucine-Rich Repeat-Containing G-Protein Coupled Receptor 5; GRP49; Leucine Rich Repeat Containing G Protein-Coupled Receptor 5; G Protein-Coupled Receptor 49
Species:  
Human
Source:  
CHO
loading...
    loading...
Cat. No.: HY-P99406
CAS No.: 2213450-26-9
Synonyms: MCLA 158

Target:  

EGFR

Research Areas:  

Cancer

Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-P10810
Target:  

Wnt β-catenin

Research Areas:  

Cancer

QPH-FR is a LGR5 inhibitor. QPH-FR competitively binds to LGR5 and prevents the formation of the LGR5/RSPO1 complex. QPH-FR promotes RNF43/ZNRF3-mediated ubiquitination of FZD receptors, inhibits the Wnt β-catenin signaling pathway, and reduces the stemness of colorectal cancer cells. QPH-FR is applicable to relevant research on colorectal cancer .
loading...
    loading...
Cat. No.: HY-P99406A

Target:  

EGFR

Research Areas:  

Cancer

Petosemtamab (FUT8-KO) is an anti-EGFR and anti-LGR5 monoclonal antibody expressed in CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Fucosyl loss enhances the ADCC effect of the antibody. Petosemtamab (FUT8-KO) leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab (FUT8-KO) can be used for research on solid tumors such as head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal cancer (CRC) .
loading...
    loading...
Cat. No.: HY-P991454

Target:  

Wnt

Research Areas:  

Inflammation/Immunology

Anti-LGR5/GPR49 Antibody (18G7H6A3) is a human monoclonal antibody (mAb) targeting LGR5/GPR49. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P990560

Target:  

Wnt

Research Areas:  

Cancer

BNC-101 is a humanized monoclonal antibody targeting GPR49/LGR5. BNC-101 binds to LGR5, thereby inhibiting LGR5-mediated signal transduction pathways. BNC-101 has antineoplastic activity .
loading...
    loading...
Cat. No.: HY-RS07619
Research Areas:  

Others

LGR5 Human Pre-designed siRNA Set A contains three designed siRNAs for LGR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS20763
Research Areas:  

Others

Lgr5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lgr5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS27277
Research Areas:  

Others

Lgr5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lgr5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P82097
Synonyms: FEX; GPR49; GPR67; GRP49; LGR5; HG38; 8

Host:  

Rabbit

Application:  

WB, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P700891
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LGR5; G-Protein Coupled Receptor HG38; Prev. GPR49; G-Protein Coupled Receptor 49; Prev. GPR67; G-Protein Coupled Receptor 67; HG38; Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5, Isoform CRA_b; FEX; Orphan G Protein-Coupled Receptor HG38; L
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P704758
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LGR5; G-Protein Coupled Receptor HG38; Prev. GPR49; G-Protein Coupled Receptor 49; Prev. GPR67; G-Protein Coupled Receptor 67; HG38; Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5, Isoform CRA_b; FEX; Orphan G Protein-Coupled Receptor HG38; L
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P704759
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LGR5; G-Protein Coupled Receptor HG38; Prev. GPR49; G-Protein Coupled Receptor 49; Prev. GPR67; G-Protein Coupled Receptor 67; HG38; Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5, Isoform CRA_b; FEX; Orphan G Protein-Coupled Receptor HG38; L
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P706156
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LGR5; G-Protein Coupled Receptor HG38; Prev. GPR49; G-Protein Coupled Receptor 49; Prev. GPR67; G-Protein Coupled Receptor 67; HG38; Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5, Isoform CRA_b; FEX; Orphan G Protein-Coupled Receptor HG38; L
Species:  
Cynomolgus
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-186001
CAS No.: 2922732-38-3
Synonyms: RM-044
Target:  

Ras β-catenin

Research Areas:  

Cancer

RMC-9945 (RM-044) is a selective, covalent, and orally active RAS (ON) G12D inhibitor. RMC-9945 enhances the transcriptional activity of β-Catenin/TCF. RMC-9945 induces cell state transition, forcing metastatic colorectal cancer cells to switch from the Emp1 + state to the Lgr5 + stem cell-like state. RMC-9945 achieves durable disease control in preclinical models of colorectal cancer with early liver metastasis, but shows reduced activity in late-stage metastasis models. RMC-9945 can be used in research related to metastatic colorectal cancer and pancreatic ductal adenocarcinoma .
loading...
    loading...
  • 1